Late-Breaking Abstract Submission: Rules and Policies


Late-breaking abstracts for ASHG 2017 were due August 31, 2017 at 8:00 pm U.S. Eastern Time.

All authors will be asked to confirm the following when submitting an abstract: (1) I have read, understand, and agree to the rules and policies; (2) I am submitting this abstract with the intent of attending the 2017 Annual Meeting and presenting; and (3) I confirm that each co-author has been informed of this abstract submission and has agreed to all information as it was submitted.

NOTE: Authors who submit abstracts are not automatically registered for the meeting. In order to participate in the meeting and make their presentations, authors must register for the meeting and cover the costs of hotel and travel.

  1. Up to four (4) of the submitted Late Breaking Abstracts will be chosen for presentation at a Plenary Session on Saturday, October 21, 2017 from 1:00-2:00 pm. Authors must be available to present on this date at this time. Abstracts not chosen for this session will not be programmed in any way, including as other oral presentations or as posters.

  2. The ASHG 2017 Program Committee reserves the right to not schedule this session if there are not enough excellent abstracts to program.

  3. An individual may be first/presenting author of only one abstract. First authors of a regular abstract may not be the first author on a late-breaking abstract. If an abstract includes co-authors, the presenting author’s name should be the first name to appear in the author listing. 

  4. There is no limit to the number of times an individual may appear as co-author on abstracts. The first author must inform and have agreement from all co-authors of the abstract submission. The first author will be required to confirm this information when submitting the abstract. The first author is also responsible for notifying all authors of any and all correspondence relating to this abstract submission.

  5. With regard to research using human subjects, ASHG endorses the protections embodied in the Basic Principles of the Declaration of Helsinki and their expansion in the regulations governing research supported by the U.S. Government (45 CFR Part 46; 56 FR 28003). ASHG does not endorse and will not publish the results of research that was not conducted in accordance with these principles. Investigations involving animals reported in abstracts must have been conducted in conformance with approved principles of the care and use of animals in research.

  6. With regard to research in which a gene or SNP is identified, the first/presenting author must present the gene symbol and/or name the identified marker at the meeting. Authors who do not conform to this policy at the meeting will be subject to sanctions as determined by the Program Committee.

  7. A complete abstract should include a statement of purpose, methods used, and a summary of results in sufficient detail to support the conclusion. Statements such as "results will be described" should be avoided.

  8. Prior Publication: Results or studies that have been published or that will be accepted for publication elsewhere prior to the submission deadline of August 31, 2017 must be disclosed and the author should make clear what new information will be presented. For purposes of this policy:

    1. Material posted on a preprint server is NOT considered previously published.

    2. Abstracts that have been accepted for presentation at other conferences are considered previously published. 

  9. Abstract Licensing Agreement/Copyright Policy: In consideration of acceptance of the abstract by The American Society of Human Genetics (ASHG), the submitting author grants ASHG a nonexclusive, perpetual, worldwide license to copy, reproduce, and publish the abstract in ASHG's online or print publication of ASHG Annual Meeting abstracts and/or other compilations or collective works to be assembled and owned by ASHG (together, "Collective Works") in any form or medium now existing or hereafter created throughout the world. The submitting author understands and agrees that ASHG shall own all rights, including copyright, in and to the Collective Works, including the right to: 

    1. Distribute, reproduce, license, display, perform, lend, lease, or transfer rights to the Collective Works to third parties,

    2. Prepare derivative works of the Collective Works, and

    3. Register the Collective Works in ASHG's own name with the U.S. Copyright Office. 

    It is understood that the submitting author and/or third parties with copyrights shall retain copyright in and to the abstract contributed by the submitting author to a Collective Work. The submitting author affirms that s/he is the author and owner of the abstract and holds all copyrights in and to the abstract, or has secured any third-party permissions necessary to grant ASHG the above rights. The submitting author is responsible for providing any related third party with a copy of this grant of rights.

  10. Publication of Abstracts: Abstracts selected for presentation and publication will be available on the ASHG 2017 website immediately after acceptance. At this time, your abstract and all information will become a matter of public record and may be referenced by ASHG, media relations staff, and others. Please review the Abstract Licensing Agreement/Copyright Policy above, as well as the Embargo Guidelines.

  11. Meeting Capture and Photography Policy: For speakers who wish to share their slides with fellow attendees, ASHG will set up a secure, slide-sharing website. Our full photography policy can be viewed here.